TABLE 1.
Antibiotic(s) | MICa (μg/ml) | Concnb (μg/ml) | Mutant frequency |
|
---|---|---|---|---|
WT | mutS | |||
Fosfomycin | 8 | 128 | 2.3 × 10−6 | 2.1 × 10−4 |
Tobramycin | 1 | 4 | 2.2 × 10−9 | 1.4 × 10−7 |
Amikacin | 1 | 16 | 2.6 × 10−9 | 1.2 × 10−7 |
Imipenem | 0.5 | 8 | 1.5 × 10−7 | 1.6 × 10−5 |
Meropenem | 0.25 | 8 | 4.2 × 10−8 | 1.3 × 10−6 |
Ceftazidime | 1 | 8 | 1.3 × 10−8 | 1.3 × 10−6 |
Ciprofloxacin | 0.1 | 1 | 1.1 × 10−9 | 9.0 × 10−7 |
Colistin | 0.5 | 2 | <1.0 × 10−10 | <1.0 × 10−10 |
Tobramycin + fosfomycin | 4 + 128 | <1.0 × 10−10 | <1.0 × 10−10 | |
Amikacin + fosfomycin | 16 + 128 | <1.0 × 10−10 | <1.0 × 10−10 | |
Imipenem + fosfomycin | 8 + 128 | 1.1 × 10−9 | 1.1 × 10−7 | |
Meropenem + fosfomycin | 8 + 128 | <1.0 × 10−10 | <1.0 × 10−10 | |
Ceftazidime + fosfomycin | 8 + 128 | <1.0 × 10−10 | 1.0 × 10−8 | |
Ciprofloxacin + fosfomycin | 1 + 128 | <1.0 × 10−10 | <1.0 × 10−10 | |
Colistin + fosfomycin | 2 + 128 | <1.0 × 10−10 | <1.0 × 10−10 |
The MICs for PA14 (WT) and its mutS derivative were identical in all cases. For all antibiotics, the MIC was determined as recommended by the CLSI (1).
Final concentration used for calculation of mutant frequency.